| Identification | Back Directory | [Name]
PRAMIRACETAM SULFATE | [CAS]
72869-16-0 | [Synonyms]
CI-879
CNS-1879
Amacetam sulfate
PRAMIRACETAM SULFATE
Pramiracetam sulphate
N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
1-PyrrolidineacetaMide, N-(2-(bis(1-Methylethyl)aMino)ethyl)-2-oxo-
N-(2-(Diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide sulfate
N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide sulfate
N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide,sulfuric acid | [EINECS(EC#)]
615-895-9 | [Molecular Formula]
C14H27N3O2.H2O4S | [MDL Number]
MFCD01688385 | [MOL File]
72869-16-0.mol | [Molecular Weight]
367.464 |
| Hazard Information | Back Directory | [Description]
Pramiracetam sulfate, together with aniracetam are two nootropics of the piracetam
family introduced in 1993 for the treatment of attention and memory disorders resulting from
degenerative or vascular disorders in the elderly. In patients with mild to moderate primary
degenerative dementia, treatment with 75-300 mg/day of pramiracetam reduced depression,anxiety, sleep disturbance, and hostility with no observable adverse reactions. Significant
improvement of performance on measures of memory, especially delayed recall, have been
observed for pramiracetam treated patients with brain injury. | [Originator]
Warner-Lambert (U.S.A.) | [Uses]
Cognition adjuvant. | [Uses]
Pramiracetam Sulfate is a nootropic and a cognition activator drug. It also increases the rate of learning of complex visual discrimination problems in young, normal rhesus monkeys. | [Brand name]
Remen; Neupramir;
Prarnistar |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|